This is a multicenter, prospective, investigational device study designed to evaluate: The safety, feasibility, and accuracy of the device, when used by pregnant individuals
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
188
Pregnant participants will use Pulsenmore ES device to assess the safety and the efficacy of the device in monitoring fetal parameters
Center for Fetal Medicine and Women's Ultrasound
Los Angeles, California, United States
University of Florida College of Medicine
Gainesville, Florida, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Mount Sinai Hospital System
New York, New York, United States
Comparison of device derived presence or absence of fetal cardiac activity to ground truth
The presence or absence of device derived fetal cardiac activity would be matched with the presence or absence of fetal cardiac activity derived by the ground truth (in-clinic ultrasound scan)
Time frame: Test to be conducted during week 14-38 of pregnancy
Comparison of device derived amniotic fluid level status, normal or abnormal, to ground truth
Comparison of device derived amniotic fluid level status, normal or abnormal, (measured by maximal vertical pocket in cm) would be matched with amniotic fluid level status derived from the ground truth (in-clinic ultrasound scan)
Time frame: Test to be conducted during week 14-38 of pregnancy
Ability to assess fetal presentation from device derived input will be compared to the ground truth
Whether fetal presentation could be assessed or could not be assessed from device derived input compared to the input from ground truth (in-clinic ultrasound scan)
Time frame: Test to be conducted during week 14-38 of pregnancy
Ability to assess placental location from device derived input will be compared to the ground truth
Whether placental location could be assessed or could not be assessed from device derived input compared to the input from ground truth (in-clinic ultrasound scan)
Time frame: Test to be conducted during week 14-38 of pregnancy
Ability to detect fetal movement from device derived input will be compared to the ground truth
Whether fetal movement could be detected or could not be detected from device derived input compared to the input from ground truth (in-clinic ultrasound scan)
Time frame: Test to be conducted during week 14-38 of pregnancy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Ability to detect fetal breathing from device derived input will be compared to the ground truth
Whether fetal breathing could be detected or could not be detected from device derived input compared to the input from ground truth (in-clinic ultrasound scan)
Time frame: Test to be conducted during week >27-38 of pregnancy